Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):113–122. doi: 10.1097/QAI.0000000000002416

TABLE 3.

Proportion of PWH With DM With Initial HbA1c >7.0% Measurement by Final Glycemic Control Status, Attending a Clinic With the Listed Clinic-Level Factor, and the Association* of Each Clinic-Level Factor With Glycemic Control Status, DC Cohort, 2011–2019

Achieved HbA1c <7%
(N = 219)
Did Not Achieve HbA1c <7%
(N = 200)
Adjusted HR*
(95% CI)
N (%) N (%)
At a clinic with an endocrinologist on staff (yes vs. no) 161 (73.5%) 123 (61.5%) 1.45 (1.03 to 2.04)
Treatment for diabetes at the clinic
 Clinic treats most patients with DM at the HIV clinic but does refer some patients to another clinic within the institution 63 (28.8%) 78 (39.0%) Ref
 Clinic treats most patients with DM at the HIV clinic and does not refer patients to another clinic within the institution 67 (30.6%) 36 (19.5%) 1.77 (1.20 to 2.61)
 Clinic does not treat most patients with DM at the HIV clinic but refers most patients to another clinic within the institution 89 (40.6%) 83 (41.5%) 1.61 (0.97 to 2.69)
At a clinic with a diabetes education program (yes vs. no) 133 (60.7%) 121 (60.5%) 1.33 (0.94 to 1.88)
At a clinic with a weight management program (yes vs. no) 120 (54.8%) 118 (59.0%) 1.23 (0.86 to 1.75)
At a clinic with a nutritionist on staff (yes vs. no) 128 (58.5%) 122 (61.0%) 1.24 (0.88 to 1.73)
At a clinic with a smoking cessation program (yes vs. no) 163 (74.4%) 142 (71.0%) 1.34 (1.03 to 1.75)
At a clinic with an on-site pharmacy (yes vs. no) 184 (84.0%) 139 (69.5%) 1.60 (0.98 to 2.62)
At a clinic with urgent care services (yes vs. no) 200 (91.3%) 155 (77.5%) 1.99 (0.98 to 4.04)
At a clinic with physician assistants on staff (yes vs. no) 73 (33.3%) 48 (24.0%) 1.15 (0.82 to 1.59)
At a clinic with nurse practitioners on staff (yes vs. no) 133 (60.7%) 111 (55.5%) 0.91 (0.58 to 1.43)
Size of HIV clinic (over 1000 patients vs. 1000 or less patients) 182 (83.1%) 153 (76.5%) 1.16 (0.80 to 1.69)

Bold indicates significant at the P<0.05 level.

Italic values indicates P<0.1.

*

Each point estimate reported in this table is the aHR for the listed clinic-level variable included as the only clinic-level variable in a model adjusted for the following individual-level variables: age, race/ethnicity, sex at birth, baseline HbA1c value, diabetes diagnosis at enrollment into the DC Cohort, use of diabetic medications (time-updated), HIV duration, and diagnosis of hypertension at start of observation.